F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 28,200 shares at $21.74 ($615K) on 2023-02-21, disclosed to the SEC on 2023-02-23.
Open-market sale of $615k TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.74 | 9,400 | $204K | 33.2% |
| 2 | $21.74 | 9,400 | $204K | 33.2% |
| 3 | $21.97 | 9,400 | $207K | 33.6% |
| Total | $21.82 avg | 28,200 | $615K | 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |